High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints

Perioperative immune checkpoint inhibitor (ICI) trials for intermediate high-risk clear cell renal cell carcinoma (ccRCC) have failed to consistently demonstrate improved patient outcomes. These unsuccessful ICI trials suggest that the tumour infiltrating immunophenotypes, termed here as the immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghubar, Arti M., Matigian, Nicholas A., Crawford, Joanna, Francis, Leo, Ellis, Robert, Healy, Helen G., Kassianos, Andrew J., Ng, Monica S. Y., Roberts, Matthew J., Wood, Simon, Mallett, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495390/
https://www.ncbi.nlm.nih.gov/pubmed/37696903
http://dx.doi.org/10.1038/s41698-023-00441-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495390/
https://www.ncbi.nlm.nih.gov/pubmed/37696903
http://dx.doi.org/10.1038/s41698-023-00441-5

Ejemplares similares